Escondido, CA, United States of America

William Earl Webler, Jr

This inventor holds 61 USPTO granted patents and 5 published patent applications and 3 EPO patents, primarily in Medical Catheter Technology (CPC class A61B). Top assignees: Abbott Cardiovascular Systems, Inc., Advanced Cardiovascular Systems, Inc., Cardiac Pacemakers, Inc.. Active years: 2002-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Earl Webler, Jr. Retrieved from https://idiyas.com/inventor/william-earl-webler-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 61 

% Patents Active = 24.6

 

Average Co-Inventor Count = 2.1

ph-index = 26

Forward Citations = 4,171(Granted Patents)

Forward Citations (Not Self Cited) = 4,090(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Newark, CA (US) (2002)
  • Temecula, CA (US) (2003)
  • Escondido, CA (US) (2004 - 2015)
  • San Jose, CA (US) (2012 - 2018)

Company Filing History:


Years Active: 2002-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Catheter
Vascular Occlusion
Agent Delivery
Infusion Systems
Electropolishing
Balloon Inflation
Ultrasound Imaging
Bio-Electric Tissue
Controlled Occlusion
Flexible Tubing
Medical Devices
Laser Cutting
61 patents (USPTO):Explore Patents

Title: William Earl Webler, Jr.: An Innovator in Coronary Treatment Technologies

Introduction

William Earl Webler, Jr. is a distinguished inventor based in Escondido, CA, known for his significant contributions to medical technologies, particularly in the field of cardiovascular treatment. With an impressive portfolio of 61 patents, he has established himself as a key figure in developing innovative solutions aimed at improving patient care.

Latest Patents

Webler's latest inventions include groundbreaking systems and methods designed for coronary treatment. One notable patent is the "System and Method for FFR Guidewire Recovery," which features a pressure sensing guidewire equipped with a pressure sensor for measuring blood pressure within a patient's vasculature. This invention includes a specialized sheath that allows for the guidewire to slide freely, providing essential usability in medical procedures.

Another pivotal patent is titled "System for the Injection of Cells and/or Biologically Active Materials into Coronary Arteries for Therapeutic Purposes." This method involves positioning a delivery device in a blood vessel and locally introducing treatment agents, followed by occluding the vessel to ensure that the agent effectively penetrates targeted capillaries in distressed areas. This method promises to enhance the therapeutic outcomes for patients undergoing treatment for coronary artery issues.

Career Highlights

Webler has contributed to notable companies in the cardiovascular sector, including Abbott Cardiovascular Systems, Inc. and Advanced Cardiovascular Systems, Inc. Throughout his career, he has focused on developing innovative medical devices that advance treatment methodologies.

Collaborations

In his journey as an inventor, Webler has collaborated with esteemed colleagues such as Gabriel Asongwe and Mina W Chow. These collaborations have further fueled the innovation process, leading to the creation of pioneering medical technologies that address critical needs in the healthcare industry.

Conclusion

William Earl Webler, Jr. stands out as a prominent inventor whose work has had a profound impact on coronary treatment technologies. His inventive spirit and dedication to advancing medical practices are evidenced by his extensive portfolio of patents and collaborations with other innovators in the field. Webler's contributions continue to shape the future of cardiovascular treatment, benefiting countless patients along the way.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…